Fig. 10.

Immunohistochemistry for MHC class II in: control RMM tumors (a), RMM tumors treated with CD11b⁺ MHC class II⁻ cells (b) and RMM tumors treated with CD11b⁺ MHC class II⁺ cells (c). Immunohistochemistry for CD163 in. control RMM tumors (d), RMM tumors treated with CD11b⁺ MHC class II⁻ cells (e) and RMM tumors treated with CD11b⁺ MHC class II⁺ cells (f). Immunohistochemistry for CD68 in. control RMM tumors (g), RMM tumors treated with CD11b⁺ MHC class II⁻ cells (h) and RMM tumors treated with CD11b⁺ MHC class II⁺ cells (i). Graphic representation of cell counts for MHC class II⁺ cells (j), CD163⁺ cells (k) and CD68⁺ cells (l). Tukey’s test, *P < 0.05, **P < 0.001, significantly different between groups indicated by bars